Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…
Pharmaceuticals, Biotechnology and Life Sciences
FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology…
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans…
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a…
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) — Franco Cavaleri, B.Sc., Ph.D.c, a distinguished biomedical research scientist and CEO…
Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 2 weeks TORONTO, March 31,…
Company announcement – No. 8 / 2025 Total number of shares and voting rights in Zealand Pharma as of March…
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration…
United States Centers for Medicare and Medicaid Services (CMS) Mandates Ryoncil® CoverageNEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Mesoblast…
SAN CARLOS, Calif., March 30, 2025 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity…